ALEXANDRIA CO. FOR PHARMACEUTICALS & CHEMICAL INDUSTRIES

Alexandria Co. For Pharmaceuticals & Chemical Industries

AXPH

EGS38341C011

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 23:00:00 26/06/2024 BST			5-day change	1st Jan Change
210.7 ^EGP	-.--%		-.--%	+18.20%

2023	Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023	CI
2022	Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022	CI

Alexandria Pharmaceuticals and Chemical Industries Co. Announces Earnings Results for the Quarter Ended September 2014

October 31, 2014 at 03:44 pm

Alexandria Pharmaceuticals and Chemical Industries Co. announced earnings results for the quarter ended September 2014. For the quarter, the company posted net profit of EGP 13.3 million against net profit of EGP 12.2 million a year ago.

Latest news about Alexandria Co. For Pharmaceuticals & Chemical Industries

Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023	11-14	CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022	19/09/22	CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2022	22/05/22	CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2021	14/02/22	CI
VAlexandria Pharmaceuticals Announces Consolidated Earnings Results for the Six Months Ended December 31, 2020	15/02/21	CI
Alexandria Co. for Pharmaceuticals and Chemical Industries Recommends Cash Dividend for Fiscal Year 2019/2020	25/08/20	CI
Alexandria Co. For Pharmaceuticals & Chemical Industries Announces Earnings Results for the Year Ended on 30 June 2020	25/08/20	CI
Alexandria Pharmaceuticals Announces Earnings Results for the Year Ended June 30, 2019	29/09/19	CI
Alexandria Co. for Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2018	13/05/19	CI
Alexandria Co. for Pharmaceuticals & Chemical Industries Reports Reviewed Earnings Results for the Period Ended December 31, 2018	11/02/19	CI
Alexandria Pharmaceuticals Reports Earnings Results for the Three Months Ended September 30, 2018	12/11/18	CI
Alexandria Pharmaceuticals Declares Cash Dividend, Payable on October 28, 2018	08/10/18	CI
Alexandria Pharmaceuticals Announces Audited Earnings Results for the Year Ended June 30, 2018	03/10/18	CI
Alexandria Pharmaceuticals Announces Earnings Results for the Nine Months Ended March 31, 2018	12/05/18	CI
Alexandria Pharmaceuticals Reports Earnings Results for the Half Year Ended December 31, 2017	13/02/18	CI
Alexandria Pharmaceuticals Announces Audited Earnings Results for the Year Ended September 30, 2017	11/11/17	CI
Alexandria Pharmaceuticals Announces Audited Earnings Results for the Year Ended June 30, 2017	07/10/17	CI
Alexandria Pharmaceuticals Declares Cash Dividend, Payable on October 26, 2017	07/10/17	CI
Alexandria Pharmaceuticals Reports Audited Earnings Results for the Year Ended June 30, 2017	05/09/17	CI
Alexandria Pharmaceuticals Announces Earnings Results for the Nine Months Ended March 31, 2017	13/05/17	CI
Alexandria Pharmaceuticals Reports Earning Results for the Six Months Ended December 31, 2016	12/02/17	CI
Alexandria Pharmaceuticals and Chemical Industries Co. Announces Earnings Results for the Quarter Ended September 2014	31/10/14	CI
Alexandria Pharmaceuticals and Chemical Industries Co. Announces Earnings Results for the Year Ended June 30, 2014	30/09/14	CI

Chart Alexandria Co. For Pharmaceuticals & Chemical Industries

Duration

Period

Chart Alexandria Co. For Pharmaceuticals & Chemical Industries

More charts

Company Profile

Alexandria Co. for Pharmaceuticals & Chemical Industries SAE specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of inflammatory, infectious, pulmonary, dermatological, cardiovascular, allergic, epileptic, gastrointestinal diseases, etc. The group also provides veterinary and medical products (adhesive tape, gauze compresses, gloves, traction kits, etc.).

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ALEXANDRIA CO. FOR PHARMACEUTICALS & CHEMICAL INDUSTRIES	+18.20%	21.94M
ELI LILLY AND COMPANY	+55.32%	815B
NOVO NORDISK A/S	+44.05%	641B
JOHNSON & JOHNSON	-6.75%	352B
MERCK & CO., INC.	+13.56%	314B
ABBVIE INC.	+10.68%	303B
ASTRAZENECA PLC	+16.57%	242B
ROCHE HOLDING AG	+2.04%	224B
NOVARTIS AG	+13.31%	218B
AMGEN INC.	+8.48%	168B

Other Pharmaceuticals

Alexandria Co. For Pharmaceuticals & Chemical Industries

Equities

AXPH

EGS38341C011

Pharmaceuticals

Alexandria Pharmaceuticals and Chemical Industries Co. Announces Earnings Results for the Quarter Ended September 2014

Latest news about Alexandria Co. For Pharmaceuticals & Chemical Industries

Chart Alexandria Co. For Pharmaceuticals & Chemical Industries

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other Pharmaceuticals